Levobupivacaine Hydrochloride from Japan
Levobupivacaine hydrochloride is the S-enantiomer of bupivacaine, offering reduced cardiotoxicity. Classified under HTS 2924.29.71.00 as an aromatic cyclic amide per additional U.S. note 3. Meets chapter requirements for separate chemically defined stereoisomers.
Duty Rate — Japan → United States
21%
Rate breakdown
9903.04.628.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide chiral HPLC analysis confirming >99% enantiomeric excess
• Include comparative toxicology data vs. racemic bupivacaine
• Declare specific rotation value for optical purity verification